0001181431-12-007985.txt : 20120213
0001181431-12-007985.hdr.sgml : 20120213
20120213063447
ACCESSION NUMBER: 0001181431-12-007985
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120201
FILED AS OF DATE: 20120213
DATE AS OF CHANGE: 20120213
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: YACHMETZ PHILIP K
CENTRAL INDEX KEY: 0001250318
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-15313
FILM NUMBER: 12595115
MAIL ADDRESS:
STREET 1: 501 LAFAYETTE AVE
CITY: WYCKOFF
STATE: NJ
ZIP: 07481
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SAVIENT PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000722104
STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
IRS NUMBER: 133033811
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE TOWER CENTER
CITY: EAST BRUNSWICK
STATE: NJ
ZIP: 08816
BUSINESS PHONE: 7324189300
MAIL ADDRESS:
STREET 1: ONE TOWER CENTER
CITY: EAST BRUNSWICK
STATE: NJ
ZIP: 08816
FORMER COMPANY:
FORMER CONFORMED NAME: BIO TECHNOLOGY GENERAL CORP
DATE OF NAME CHANGE: 19920703
4
1
rrd333862.xml
X0304
4
2012-02-01
0
0000722104
SAVIENT PHARMACEUTICALS INC
SVNT
0001250318
YACHMETZ PHILIP K
SAVIENT PHARMACEUTICALS, INC.
ONE TOWER CENTER, 14TH FLOOR
EAST BRUNSWICK
NJ
08816
0
1
0
0
SVP, General Counsel
Common Stock, $.01 par value
2012-02-01
4
A
0
50000
2.26
A
239024
D
Option to Purchase Common Stock, $01 par value
2.26
2012-02-01
4
A
0
100000
2.26
A
2013-02-01
2022-02-01
Common Stock, $.01 par value per share
100000
100000
D
The right to receive these shares is pursuant to a restricted stock grant that vests as to 50% on each of the first and second anniversaries of the grant date, provided that the grantee remains employed by the Company on these dates.
These options vest as to 25% on each of the first four anniversaries of the grant date, provided that the grantee remains employed by the Company on these dates.
/s/ Irina Ishak for Philip K. Yachmetz
2012-02-13